Theodora A Constantin
Theodora A Constantin
1Imperial Centre for Translational and Experimental Medicine, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London, UK
1,
Anabel Varela-Carver
Anabel Varela-Carver
1Imperial Centre for Translational and Experimental Medicine, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London, UK
1,
Kyle K Greenland
Kyle K Greenland
1Imperial Centre for Translational and Experimental Medicine, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London, UK
1,
Gilberto Serrano de Almeida
Gilberto Serrano de Almeida
1Imperial Centre for Translational and Experimental Medicine, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London, UK
1,
Ellen Olden
Ellen Olden
1Imperial Centre for Translational and Experimental Medicine, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London, UK
1,
Lucy Penfold
Lucy Penfold
2MRC London Institute of Medical Sciences, Imperial College London, Hammersmith Hospital, London, UK
2,
Simon Ang
Simon Ang
1Imperial Centre for Translational and Experimental Medicine, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London, UK
1,
Alice Ormrod
Alice Ormrod
1Imperial Centre for Translational and Experimental Medicine, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London, UK
1,
Damien A Leach
Damien A Leach
1Imperial Centre for Translational and Experimental Medicine, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London, UK
1,
Chun-Fui Lai
Chun-Fui Lai
1Imperial Centre for Translational and Experimental Medicine, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London, UK
1,
Edward K Ainscow
Edward K Ainscow
3Carrick Therapeutics, Nova UCD, Bellfield Innovation Park, Dublin, 4 Ireland
3,
Ash K Bahl
Ash K Bahl
3Carrick Therapeutics, Nova UCD, Bellfield Innovation Park, Dublin, 4 Ireland
3,
David Carling
David Carling
2MRC London Institute of Medical Sciences, Imperial College London, Hammersmith Hospital, London, UK
2,
Matthew J Fuchter
Matthew J Fuchter
4Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, White City Campus, London, UK
4,
Simak Ali
Simak Ali
1Imperial Centre for Translational and Experimental Medicine, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London, UK
1,
Charlotte L Bevan
Charlotte L Bevan
1Imperial Centre for Translational and Experimental Medicine, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London, UK
1,✉
1Imperial Centre for Translational and Experimental Medicine, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London, UK
2MRC London Institute of Medical Sciences, Imperial College London, Hammersmith Hospital, London, UK
3Carrick Therapeutics, Nova UCD, Bellfield Innovation Park, Dublin, 4 Ireland
4Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, White City Campus, London, UK
Subject terms: Prostate cancer, Molecular biology
© The Author(s) 2024
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.